

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | sulfation (GO:0051923) | 6.15032984 |
| 2 | behavioral response to nicotine (GO:0035095) | 4.89807670 |
| 3 | mitochondrial respiratory chain complex I biogenesis (GO:0097031) | 4.58143343 |
| 4 | mitochondrial respiratory chain complex I assembly (GO:0032981) | 4.58143343 |
| 5 | NADH dehydrogenase complex assembly (GO:0010257) | 4.58143343 |
| 6 | DNA deamination (GO:0045006) | 4.51661608 |
| 7 | cell proliferation in forebrain (GO:0021846) | 4.46328671 |
| 8 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 4.05387539 |
| 9 | protein complex biogenesis (GO:0070271) | 4.04723203 |
| 10 | gamma-aminobutyric acid transport (GO:0015812) | 4.00210930 |
| 11 | cellular response to ATP (GO:0071318) | 3.96127385 |
| 12 | water-soluble vitamin biosynthetic process (GO:0042364) | 3.95876893 |
| 13 | regulation of glomerulus development (GO:0090192) | 3.90153265 |
| 14 | regulation of germinal center formation (GO:0002634) | 3.81144732 |
| 15 | somite development (GO:0061053) | 3.75413772 |
| 16 | mitochondrial respiratory chain complex assembly (GO:0033108) | 3.63622769 |
| 17 | protein polyglutamylation (GO:0018095) | 3.58214157 |
| 18 | interferon-gamma secretion (GO:0072643) | 3.56596987 |
| 19 | DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 cla | 3.54989569 |
| 20 | dentate gyrus development (GO:0021542) | 3.47726819 |
| 21 | detection of light stimulus involved in visual perception (GO:0050908) | 3.46951357 |
| 22 | detection of light stimulus involved in sensory perception (GO:0050962) | 3.46951357 |
| 23 | positive regulation of cAMP-mediated signaling (GO:0043950) | 3.44235599 |
| 24 | negative regulation of telomere maintenance (GO:0032205) | 3.42583448 |
| 25 | pharyngeal system development (GO:0060037) | 3.39559274 |
| 26 | positive regulation of potassium ion transmembrane transport (GO:1901381) | 3.38737059 |
| 27 | cellular response to exogenous dsRNA (GO:0071360) | 3.27062268 |
| 28 | membrane repolarization during cardiac muscle cell action potential (GO:0086013) | 3.22419871 |
| 29 | regulation of mesoderm development (GO:2000380) | 3.21102007 |
| 30 | DNA damage response, signal transduction resulting in transcription (GO:0042772) | 3.17369579 |
| 31 | response to xenobiotic stimulus (GO:0009410) | 3.13993059 |
| 32 | magnesium ion transport (GO:0015693) | 3.03666631 |
| 33 | positive regulation of defense response to virus by host (GO:0002230) | 3.03068067 |
| 34 | 3-phosphoadenosine 5-phosphosulfate metabolic process (GO:0050427) | 2.98354304 |
| 35 | purine ribonucleoside bisphosphate metabolic process (GO:0034035) | 2.98354304 |
| 36 | transmission of nerve impulse (GO:0019226) | 2.96899515 |
| 37 | activated T cell proliferation (GO:0050798) | 2.96320791 |
| 38 | indolalkylamine metabolic process (GO:0006586) | 2.94773884 |
| 39 | response to pheromone (GO:0019236) | 2.91161957 |
| 40 | regulation of DNA endoreduplication (GO:0032875) | 2.88680912 |
| 41 | ovulation cycle (GO:0042698) | 2.88194056 |
| 42 | membrane repolarization during action potential (GO:0086011) | 2.87632540 |
| 43 | cellular anion homeostasis (GO:0030002) | 2.86186940 |
| 44 | preassembly of GPI anchor in ER membrane (GO:0016254) | 2.85166218 |
| 45 | negative regulation of systemic arterial blood pressure (GO:0003085) | 2.81140543 |
| 46 | neuronal action potential (GO:0019228) | 2.80548598 |
| 47 | regulation of cell proliferation involved in kidney development (GO:1901722) | 2.80506921 |
| 48 | negative regulation of transcription regulatory region DNA binding (GO:2000678) | 2.78749593 |
| 49 | indole-containing compound catabolic process (GO:0042436) | 2.78704787 |
| 50 | indolalkylamine catabolic process (GO:0046218) | 2.78704787 |
| 51 | tryptophan catabolic process (GO:0006569) | 2.78704787 |
| 52 | positive regulation of synapse maturation (GO:0090129) | 2.75758872 |
| 53 | regulation of skeletal muscle contraction (GO:0014819) | 2.73762163 |
| 54 | negative regulation of mast cell activation (GO:0033004) | 2.72751276 |
| 55 | kynurenine metabolic process (GO:0070189) | 2.71955196 |
| 56 | positive regulation of triglyceride biosynthetic process (GO:0010867) | 2.69484397 |
| 57 | epithelial to mesenchymal transition involved in endocardial cushion formation (GO:0003198) | 2.67251929 |
| 58 | parturition (GO:0007567) | 2.67233369 |
| 59 | positive regulation of fatty acid oxidation (GO:0046321) | 2.65446176 |
| 60 | positive regulation of glomerulus development (GO:0090193) | 2.65430036 |
| 61 | primary amino compound metabolic process (GO:1901160) | 2.63871777 |
| 62 | cornea development in camera-type eye (GO:0061303) | 2.63576290 |
| 63 | positive regulation of fatty acid transport (GO:2000193) | 2.62702880 |
| 64 | serotonin metabolic process (GO:0042428) | 2.61940342 |
| 65 | L-fucose catabolic process (GO:0042355) | 2.60384963 |
| 66 | fucose catabolic process (GO:0019317) | 2.60384963 |
| 67 | L-fucose metabolic process (GO:0042354) | 2.60384963 |
| 68 | adaptation of signaling pathway (GO:0023058) | 2.60243677 |
| 69 | regulation of collateral sprouting (GO:0048670) | 2.57040523 |
| 70 | indole-containing compound metabolic process (GO:0042430) | 2.56572602 |
| 71 | regulation of single stranded viral RNA replication via double stranded DNA intermediate (GO:0045091 | 2.56297480 |
| 72 | endoderm formation (GO:0001706) | 2.54931953 |
| 73 | regulation of female receptivity (GO:0045924) | 2.54384823 |
| 74 | regulation of synapse maturation (GO:0090128) | 2.53645471 |
| 75 | otic vesicle formation (GO:0030916) | 2.53410186 |
| 76 | membrane depolarization during action potential (GO:0086010) | 2.51652836 |
| 77 | lung morphogenesis (GO:0060425) | 2.51262634 |
| 78 | positive regulation of T cell apoptotic process (GO:0070234) | 2.49942756 |
| 79 | positive regulation of cardiac muscle cell differentiation (GO:2000727) | 2.49598832 |
| 80 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 2.48724525 |
| 81 | ATP synthesis coupled proton transport (GO:0015986) | 2.48724525 |
| 82 | negative regulation of astrocyte differentiation (GO:0048712) | 2.47550139 |
| 83 | reflex (GO:0060004) | 2.47350105 |
| 84 | negative regulation of appetite (GO:0032099) | 2.47277677 |
| 85 | negative regulation of response to food (GO:0032096) | 2.47277677 |
| 86 | tRNA splicing, via endonucleolytic cleavage and ligation (GO:0006388) | 2.47269257 |
| 87 | RNA splicing, via endonucleolytic cleavage and ligation (GO:0000394) | 2.47269257 |
| 88 | regulation of action potential (GO:0098900) | 2.47116490 |
| 89 | negative regulation of platelet-derived growth factor receptor signaling pathway (GO:0010642) | 2.46306840 |
| 90 | regulation of phospholipid biosynthetic process (GO:0071071) | 2.46169452 |
| 91 | negative regulation of T cell differentiation in thymus (GO:0033085) | 2.45691410 |
| 92 | regulation of membrane repolarization (GO:0060306) | 2.45061192 |
| 93 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 2.37239250 |
| 94 | regulation of transcription regulatory region DNA binding (GO:2000677) | 2.36783997 |
| 95 | DNA methylation involved in gamete generation (GO:0043046) | 2.35850635 |
| 96 | positive regulation of icosanoid secretion (GO:0032305) | 2.35705728 |
| 97 | retinal ganglion cell axon guidance (GO:0031290) | 2.35176121 |
| 98 | regulation of rhodopsin mediated signaling pathway (GO:0022400) | 2.35108061 |
| 99 | spinal cord development (GO:0021510) | 2.34689206 |
| 100 | GPI anchor metabolic process (GO:0006505) | 2.33907941 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 5.44680207 |
| 2 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 3.35778562 |
| 3 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 2.96755662 |
| 4 | ZNF274_21170338_ChIP-Seq_K562_Hela | 2.73981474 |
| 5 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 2.58583943 |
| 6 | GBX2_23144817_ChIP-Seq_PC3_Human | 2.40874971 |
| 7 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 2.40537110 |
| 8 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 2.39086594 |
| 9 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.34711157 |
| 10 | VDR_22108803_ChIP-Seq_LS180_Human | 2.32714257 |
| 11 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 2.19667090 |
| 12 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 2.12693117 |
| 13 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.08959886 |
| 14 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.08823002 |
| 15 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 2.04344025 |
| 16 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.97204253 |
| 17 | * HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.91891556 |
| 18 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.89931933 |
| 19 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.84659732 |
| 20 | EWS_26573619_Chip-Seq_HEK293_Human | 1.82494815 |
| 21 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.78660799 |
| 22 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.77254465 |
| 23 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.71271997 |
| 24 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.71117735 |
| 25 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.67660459 |
| 26 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.67020021 |
| 27 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.66560708 |
| 28 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.66020866 |
| 29 | REST_21632747_ChIP-Seq_MESCs_Mouse | 1.63880275 |
| 30 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.60501745 |
| 31 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.60501745 |
| 32 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.57620496 |
| 33 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.57493311 |
| 34 | IRF1_19129219_ChIP-ChIP_H3396_Human | 1.56480997 |
| 35 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.53293449 |
| 36 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.53068759 |
| 37 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 1.52918814 |
| 38 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.51248973 |
| 39 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.46199013 |
| 40 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.45149867 |
| 41 | * EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 1.42870418 |
| 42 | FUS_26573619_Chip-Seq_HEK293_Human | 1.40959136 |
| 43 | P300_19829295_ChIP-Seq_ESCs_Human | 1.39909097 |
| 44 | TP53_20018659_ChIP-ChIP_R1E_Mouse | 1.39555798 |
| 45 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.39021712 |
| 46 | MYC_18940864_ChIP-ChIP_HL60_Human | 1.37812854 |
| 47 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.32568553 |
| 48 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.30367303 |
| 49 | TDRD3_21172665_ChIP-Seq_MCF-7_Human | 1.28576043 |
| 50 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.27243013 |
| 51 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 1.26737057 |
| 52 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.24415145 |
| 53 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.24373351 |
| 54 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 1.22276975 |
| 55 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.21498469 |
| 56 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 1.18097277 |
| 57 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.17448272 |
| 58 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 1.17311841 |
| 59 | TP63_19390658_ChIP-ChIP_HaCaT_Human | 1.15890175 |
| 60 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.15712343 |
| 61 | POU5F1_16153702_ChIP-ChIP_HESCs_Human | 1.15256848 |
| 62 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.11025872 |
| 63 | NCOR_22424771_ChIP-Seq_293T_Human | 1.10924060 |
| 64 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.10593577 |
| 65 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 1.10036412 |
| 66 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.09865459 |
| 67 | TP53_22573176_ChIP-Seq_HFKS_Human | 1.09299050 |
| 68 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.05846873 |
| 69 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.05767727 |
| 70 | FOXA1_27270436_Chip-Seq_PROSTATE_Human | 1.04161703 |
| 71 | FOXA1_25329375_ChIP-Seq_VCAP_Human | 1.04161703 |
| 72 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 1.03377377 |
| 73 | ERA_21632823_ChIP-Seq_H3396_Human | 1.02840050 |
| 74 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.02463525 |
| 75 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 1.02463525 |
| 76 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.02109152 |
| 77 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.01323464 |
| 78 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.01306004 |
| 79 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.00851493 |
| 80 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.00653862 |
| 81 | GATA3_21878914_ChIP-Seq_MCF-7_Human | 1.00537558 |
| 82 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.00457934 |
| 83 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.98059057 |
| 84 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.97618125 |
| 85 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 0.95972490 |
| 86 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 0.95148587 |
| 87 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 0.94401244 |
| 88 | NANOG_20526341_ChIP-Seq_ESCs_Human | 0.93319094 |
| 89 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 0.92955348 |
| 90 | TAF2_19829295_ChIP-Seq_ESCs_Human | 0.92114979 |
| 91 | TCF4_23295773_ChIP-Seq_U87_Human | 0.92037091 |
| 92 | STAT3_23295773_ChIP-Seq_U87_Human | 0.91432706 |
| 93 | SOX2_19829295_ChIP-Seq_ESCs_Human | 0.91263450 |
| 94 | NANOG_19829295_ChIP-Seq_ESCs_Human | 0.91263450 |
| 95 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 0.90073675 |
| 96 | CBP_20019798_ChIP-Seq_JUKART_Human | 0.90073675 |
| 97 | AR_25329375_ChIP-Seq_VCAP_Human | 0.89107786 |
| 98 | LMO2_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.88876633 |
| 99 | FLI1_21867929_ChIP-Seq_TH2_Mouse | 0.88135213 |
| 100 | CEBPA_26348894_ChIP-Seq_LIVER_Mouse | 0.87373616 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005646_abnormal_pituitary_gland | 2.99626466 |
| 2 | MP0006292_abnormal_olfactory_placode | 2.80883022 |
| 3 | MP0004885_abnormal_endolymph | 2.72099118 |
| 4 | MP0002160_abnormal_reproductive_system | 2.65765479 |
| 5 | MP0001968_abnormal_touch/_nociception | 2.38356461 |
| 6 | MP0002138_abnormal_hepatobiliary_system | 2.35749912 |
| 7 | MP0005389_reproductive_system_phenotype | 2.23976681 |
| 8 | MP0002837_dystrophic_cardiac_calcinosis | 2.23535746 |
| 9 | MP0000049_abnormal_middle_ear | 2.19359501 |
| 10 | MP0003646_muscle_fatigue | 2.17432218 |
| 11 | MP0008877_abnormal_DNA_methylation | 2.09166933 |
| 12 | MP0004142_abnormal_muscle_tone | 2.05258516 |
| 13 | MP0000631_abnormal_neuroendocrine_gland | 2.04219180 |
| 14 | MP0002272_abnormal_nervous_system | 1.99483753 |
| 15 | MP0002653_abnormal_ependyma_morphology | 1.99457471 |
| 16 | MP0002102_abnormal_ear_morphology | 1.92614396 |
| 17 | MP0006072_abnormal_retinal_apoptosis | 1.91517445 |
| 18 | MP0008872_abnormal_physiological_respon | 1.85764063 |
| 19 | MP0002736_abnormal_nociception_after | 1.84371924 |
| 20 | MP0004145_abnormal_muscle_electrophysio | 1.82005005 |
| 21 | MP0005551_abnormal_eye_electrophysiolog | 1.81849172 |
| 22 | MP0009745_abnormal_behavioral_response | 1.77057470 |
| 23 | MP0001485_abnormal_pinna_reflex | 1.75603631 |
| 24 | MP0002163_abnormal_gland_morphology | 1.75502561 |
| 25 | MP0004133_heterotaxia | 1.69485397 |
| 26 | MP0005645_abnormal_hypothalamus_physiol | 1.67852624 |
| 27 | MP0003011_delayed_dark_adaptation | 1.63433842 |
| 28 | MP0002735_abnormal_chemical_nociception | 1.62845372 |
| 29 | MP0001440_abnormal_grooming_behavior | 1.56189618 |
| 30 | MP0005671_abnormal_response_to | 1.52160059 |
| 31 | MP0004134_abnormal_chest_morphology | 1.45825731 |
| 32 | MP0002064_seizures | 1.45188330 |
| 33 | MP0002733_abnormal_thermal_nociception | 1.44692562 |
| 34 | MP0005379_endocrine/exocrine_gland_phen | 1.41056870 |
| 35 | MP0000678_abnormal_parathyroid_gland | 1.40382360 |
| 36 | MP0001919_abnormal_reproductive_system | 1.37301548 |
| 37 | MP0002277_abnormal_respiratory_mucosa | 1.37069270 |
| 38 | MP0001970_abnormal_pain_threshold | 1.35627340 |
| 39 | MP0003635_abnormal_synaptic_transmissio | 1.34935082 |
| 40 | MP0004742_abnormal_vestibular_system | 1.34692869 |
| 41 | MP0001502_abnormal_circadian_rhythm | 1.32317379 |
| 42 | MP0001905_abnormal_dopamine_level | 1.31686931 |
| 43 | MP0002876_abnormal_thyroid_physiology | 1.30625015 |
| 44 | MP0009046_muscle_twitch | 1.27959347 |
| 45 | MP0009250_abnormal_appendicular_skeleto | 1.26868251 |
| 46 | MP0000026_abnormal_inner_ear | 1.24449893 |
| 47 | MP0002572_abnormal_emotion/affect_behav | 1.23175370 |
| 48 | MP0005253_abnormal_eye_physiology | 1.22151511 |
| 49 | MP0005084_abnormal_gallbladder_morpholo | 1.21738744 |
| 50 | MP0001486_abnormal_startle_reflex | 1.21655975 |
| 51 | MP0003283_abnormal_digestive_organ | 1.19414322 |
| 52 | MP0003195_calcinosis | 1.17893058 |
| 53 | MP0003880_abnormal_central_pattern | 1.16039471 |
| 54 | MP0002557_abnormal_social/conspecific_i | 1.15151861 |
| 55 | MP0003938_abnormal_ear_development | 1.14656162 |
| 56 | MP0002938_white_spotting | 1.12554536 |
| 57 | MP0006276_abnormal_autonomic_nervous | 1.12244436 |
| 58 | MP0002928_abnormal_bile_duct | 1.11766032 |
| 59 | MP0001963_abnormal_hearing_physiology | 1.10322695 |
| 60 | MP0003567_abnormal_fetal_cardiomyocyte | 1.08205690 |
| 61 | MP0002063_abnormal_learning/memory/cond | 1.06952338 |
| 62 | MP0002734_abnormal_mechanical_nocicepti | 1.06422794 |
| 63 | MP0004130_abnormal_muscle_cell | 1.03695653 |
| 64 | MP0003119_abnormal_digestive_system | 1.01500222 |
| 65 | MP0000685_abnormal_immune_system | 1.00862046 |
| 66 | MP0003787_abnormal_imprinting | 0.98934190 |
| 67 | MP0001348_abnormal_lacrimal_gland | 0.94245128 |
| 68 | MP0001986_abnormal_taste_sensitivity | 0.93216543 |
| 69 | MP0005174_abnormal_tail_pigmentation | 0.92986802 |
| 70 | MP0009379_abnormal_foot_pigmentation | 0.92953630 |
| 71 | MP0000372_irregular_coat_pigmentation | 0.91130582 |
| 72 | MP0002234_abnormal_pharynx_morphology | 0.90936889 |
| 73 | MP0002752_abnormal_somatic_nervous | 0.90875285 |
| 74 | MP0000613_abnormal_salivary_gland | 0.88812294 |
| 75 | MP0003879_abnormal_hair_cell | 0.88462903 |
| 76 | MP0005195_abnormal_posterior_eye | 0.88364639 |
| 77 | MP0002067_abnormal_sensory_capabilities | 0.86936634 |
| 78 | MP0003724_increased_susceptibility_to | 0.86476396 |
| 79 | MP0002184_abnormal_innervation | 0.85714575 |
| 80 | MP0009053_abnormal_anal_canal | 0.84888399 |
| 81 | MP0008875_abnormal_xenobiotic_pharmacok | 0.83413636 |
| 82 | MP0000569_abnormal_digit_pigmentation | 0.83348722 |
| 83 | MP0001501_abnormal_sleep_pattern | 0.79753682 |
| 84 | MP0004859_abnormal_synaptic_plasticity | 0.79225437 |
| 85 | MP0002932_abnormal_joint_morphology | 0.78041307 |
| 86 | MP0002249_abnormal_larynx_morphology | 0.77413601 |
| 87 | MP0001529_abnormal_vocalization | 0.76685888 |
| 88 | MP0008789_abnormal_olfactory_epithelium | 0.75724227 |
| 89 | MP0001764_abnormal_homeostasis | 0.74276408 |
| 90 | MP0000230_abnormal_systemic_arterial | 0.74024323 |
| 91 | MP0001188_hyperpigmentation | 0.73416482 |
| 92 | MP0009765_abnormal_xenobiotic_induced | 0.73333124 |
| 93 | MP0003638_abnormal_response/metabolism_ | 0.73083733 |
| 94 | MP0003937_abnormal_limbs/digits/tail_de | 0.72324474 |
| 95 | MP0001873_stomach_inflammation | 0.72081892 |
| 96 | MP0004147_increased_porphyrin_level | 0.68300875 |
| 97 | MP0005410_abnormal_fertilization | 0.66539495 |
| 98 | MP0005386_behavior/neurological_phenoty | 0.65918810 |
| 99 | MP0004924_abnormal_behavior | 0.65918810 |
| 100 | MP0001765_abnormal_ion_homeostasis | 0.65820284 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Pancreatic cysts (HP:0001737) | 3.80530637 |
| 2 | Pendular nystagmus (HP:0012043) | 3.74381899 |
| 3 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 3.69030164 |
| 4 | Abolished electroretinogram (ERG) (HP:0000550) | 3.64048274 |
| 5 | Conjunctival hamartoma (HP:0100780) | 3.57392015 |
| 6 | Pancreatic fibrosis (HP:0100732) | 3.53522407 |
| 7 | Congenital stationary night blindness (HP:0007642) | 3.47729369 |
| 8 | True hermaphroditism (HP:0010459) | 3.47282618 |
| 9 | Abnormality of the proximal phalanges of the hand (HP:0009834) | 3.39309044 |
| 10 | Genetic anticipation (HP:0003743) | 3.37658248 |
| 11 | Abnormality of midbrain morphology (HP:0002418) | 3.18885160 |
| 12 | Molar tooth sign on MRI (HP:0002419) | 3.18885160 |
| 13 | Abnormal rod and cone electroretinograms (HP:0008323) | 3.15986551 |
| 14 | Abnormality of the middle phalanx of the 5th finger (HP:0004219) | 3.09933907 |
| 15 | Progressive cerebellar ataxia (HP:0002073) | 3.07050702 |
| 16 | Abnormality of the middle phalanges of the toes (HP:0010183) | 2.97284190 |
| 17 | Asplenia (HP:0001746) | 2.96544359 |
| 18 | Nephronophthisis (HP:0000090) | 2.95221254 |
| 19 | Decreased central vision (HP:0007663) | 2.93016459 |
| 20 | Abnormality of the phalanges of the 2nd finger (HP:0009541) | 2.87539935 |
| 21 | Abnormality of the phalanges of the 5th finger (HP:0004213) | 2.85667073 |
| 22 | Aplasia/Hypoplasia of the spleen (HP:0010451) | 2.85049810 |
| 23 | Keratoconus (HP:0000563) | 2.84730735 |
| 24 | Increased corneal curvature (HP:0100692) | 2.84730735 |
| 25 | Hamartoma of the eye (HP:0010568) | 2.84339573 |
| 26 | Hypoplasia of the uterus (HP:0000013) | 2.82518183 |
| 27 | Furrowed tongue (HP:0000221) | 2.73084369 |
| 28 | Abnormal number of erythroid precursors (HP:0012131) | 2.66490287 |
| 29 | Abnormality of DNA repair (HP:0003254) | 2.63611440 |
| 30 | Aplasia/Hypoplasia of the 1st metacarpal (HP:0010026) | 2.59769869 |
| 31 | Short 1st metacarpal (HP:0010034) | 2.59769869 |
| 32 | Decreased electroretinogram (ERG) amplitude (HP:0000654) | 2.59196341 |
| 33 | Aplasia/hypoplasia of the uterus (HP:0008684) | 2.51528146 |
| 34 | Severe visual impairment (HP:0001141) | 2.46753295 |
| 35 | Symphalangism affecting the phalanges of the hand (HP:0009773) | 2.46444994 |
| 36 | Attenuation of retinal blood vessels (HP:0007843) | 2.46121740 |
| 37 | Short femoral neck (HP:0100864) | 2.41442855 |
| 38 | Short hallux (HP:0010109) | 2.40100182 |
| 39 | Methylmalonic acidemia (HP:0002912) | 2.39673756 |
| 40 | Cystic liver disease (HP:0006706) | 2.37978098 |
| 41 | Abnormality of the renal medulla (HP:0100957) | 2.34597964 |
| 42 | Abnormality of cells of the erythroid lineage (HP:0012130) | 2.31713253 |
| 43 | Abnormality of the renal cortex (HP:0011035) | 2.28463928 |
| 44 | Type II lissencephaly (HP:0007260) | 2.27798181 |
| 45 | Mitochondrial inheritance (HP:0001427) | 2.27760622 |
| 46 | Congenital sensorineural hearing impairment (HP:0008527) | 2.26973063 |
| 47 | Aplasia/Hypoplasia of the hallux (HP:0008362) | 2.26282289 |
| 48 | Congenital, generalized hypertrichosis (HP:0004540) | 2.24964745 |
| 49 | Abnormality of the 1st metacarpal (HP:0010009) | 2.24458612 |
| 50 | Sclerocornea (HP:0000647) | 2.22905154 |
| 51 | Morphological abnormality of the middle ear (HP:0008609) | 2.21782745 |
| 52 | Gaze-evoked nystagmus (HP:0000640) | 2.20776169 |
| 53 | 3-Methylglutaconic aciduria (HP:0003535) | 2.20675149 |
| 54 | Agitation (HP:0000713) | 2.20022905 |
| 55 | Aplasia/Hypoplasia of the tibia (HP:0005772) | 2.19049080 |
| 56 | Bone cyst (HP:0012062) | 2.14230762 |
| 57 | Male pseudohermaphroditism (HP:0000037) | 2.14136768 |
| 58 | Short tibia (HP:0005736) | 2.13114365 |
| 59 | Abnormality of the nasal septum (HP:0000419) | 2.13072944 |
| 60 | Bony spicule pigmentary retinopathy (HP:0007737) | 2.12426661 |
| 61 | Aplasia/Hypoplasia of the phalanges of the toes (HP:0010173) | 2.12069589 |
| 62 | Aplasia/Hypoplasia involving the femoral head and neck (HP:0009108) | 2.11789202 |
| 63 | Aplasia/Hypoplasia of the patella (HP:0006498) | 2.08387217 |
| 64 | Meningioma (HP:0002858) | 2.08126209 |
| 65 | Hepatocellular necrosis (HP:0001404) | 2.04833291 |
| 66 | Septo-optic dysplasia (HP:0100842) | 2.03564541 |
| 67 | Chronic hepatic failure (HP:0100626) | 2.02368640 |
| 68 | Fibular aplasia (HP:0002990) | 2.02318786 |
| 69 | Methylmalonic aciduria (HP:0012120) | 2.02000100 |
| 70 | Hypoplastic pelvis (HP:0008839) | 2.01696237 |
| 71 | Anomalous pulmonary venous return (HP:0010772) | 1.99759951 |
| 72 | Goiter (HP:0000853) | 1.98928345 |
| 73 | Chorioretinal atrophy (HP:0000533) | 1.98491479 |
| 74 | Absent/shortened dynein arms (HP:0200106) | 1.98463497 |
| 75 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 1.98463497 |
| 76 | Acute necrotizing encephalopathy (HP:0006965) | 1.97256528 |
| 77 | Mesomelia (HP:0003027) | 1.96482688 |
| 78 | Increased CSF lactate (HP:0002490) | 1.95921988 |
| 79 | Adactyly (HP:0009776) | 1.94485920 |
| 80 | Aplasia/Hypoplasia involving the pelvis (HP:0009103) | 1.92510993 |
| 81 | Abnormality of the renal collecting system (HP:0004742) | 1.89206877 |
| 82 | Concave nail (HP:0001598) | 1.87961127 |
| 83 | Small hand (HP:0200055) | 1.87498764 |
| 84 | Medial flaring of the eyebrow (HP:0010747) | 1.87126970 |
| 85 | Synostosis of carpal bones (HP:0005048) | 1.86702615 |
| 86 | Hypoplasia of the ulna (HP:0003022) | 1.81056423 |
| 87 | Anencephaly (HP:0002323) | 1.80541737 |
| 88 | Clumsiness (HP:0002312) | 1.80203512 |
| 89 | IgG deficiency (HP:0004315) | 1.79218702 |
| 90 | Short 4th metacarpal (HP:0010044) | 1.78987244 |
| 91 | Aplasia/Hypoplasia of the 4th metacarpal (HP:0010042) | 1.78987244 |
| 92 | Tubular atrophy (HP:0000092) | 1.78603265 |
| 93 | Polydipsia (HP:0001959) | 1.78393793 |
| 94 | Abnormal drinking behavior (HP:0030082) | 1.78393793 |
| 95 | Prostate neoplasm (HP:0100787) | 1.78054981 |
| 96 | Visual hallucinations (HP:0002367) | 1.76731619 |
| 97 | Adrenal hypoplasia (HP:0000835) | 1.76721075 |
| 98 | Abnormality of the 4th metacarpal (HP:0010012) | 1.76279188 |
| 99 | Megalencephaly (HP:0001355) | 1.74410151 |
| 100 | Aplasia/Hypoplasia of the fibula (HP:0006492) | 1.74142229 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ADRBK2 | 3.68109562 |
| 2 | FRK | 3.59851486 |
| 3 | GRK1 | 3.30771032 |
| 4 | TAOK3 | 2.78078378 |
| 5 | VRK2 | 2.69355007 |
| 6 | NUAK1 | 2.48196748 |
| 7 | TAF1 | 2.45977234 |
| 8 | PINK1 | 2.35438879 |
| 9 | MAP4K2 | 2.28830149 |
| 10 | BCKDK | 2.24673253 |
| 11 | TXK | 2.21433311 |
| 12 | TLK1 | 2.15475781 |
| 13 | BMPR1B | 1.86064347 |
| 14 | ZAK | 1.77630493 |
| 15 | PRKD2 | 1.64019310 |
| 16 | WNK3 | 1.60125353 |
| 17 | IKBKB | 1.53326685 |
| 18 | GRK7 | 1.53086787 |
| 19 | DYRK2 | 1.51505015 |
| 20 | MAPK13 | 1.49112627 |
| 21 | WNK4 | 1.47513440 |
| 22 | VRK1 | 1.37115296 |
| 23 | GRK5 | 1.36756656 |
| 24 | INSRR | 1.31720799 |
| 25 | NME2 | 1.31245418 |
| 26 | TNIK | 1.26559653 |
| 27 | ADRBK1 | 1.26215983 |
| 28 | DAPK2 | 1.25168410 |
| 29 | CSNK1G2 | 1.24559140 |
| 30 | RPS6KA6 | 1.18653108 |
| 31 | CSNK1G3 | 1.15945646 |
| 32 | MAPKAPK3 | 1.11717458 |
| 33 | CASK | 1.08183350 |
| 34 | TIE1 | 1.04886766 |
| 35 | MAPKAPK5 | 1.03198863 |
| 36 | PRKCG | 0.99249189 |
| 37 | CSNK1G1 | 0.95666253 |
| 38 | GRK6 | 0.93420548 |
| 39 | CSNK1A1L | 0.93085299 |
| 40 | SGK2 | 0.90925379 |
| 41 | KIT | 0.90440505 |
| 42 | STK16 | 0.90131755 |
| 43 | PLK2 | 0.89378301 |
| 44 | PAK3 | 0.89058996 |
| 45 | DYRK3 | 0.88660858 |
| 46 | TEC | 0.88614825 |
| 47 | PKN1 | 0.88364704 |
| 48 | MAP4K1 | 0.87310956 |
| 49 | MAP3K4 | 0.86485893 |
| 50 | RPS6KL1 | 0.86148697 |
| 51 | RPS6KC1 | 0.86148697 |
| 52 | MAP2K6 | 0.81760685 |
| 53 | ACVR1B | 0.81431617 |
| 54 | PRKCE | 0.80073446 |
| 55 | ABL2 | 0.79082844 |
| 56 | MAP2K7 | 0.78836015 |
| 57 | NTRK2 | 0.77221438 |
| 58 | SIK2 | 0.74769483 |
| 59 | TNK2 | 0.74321189 |
| 60 | SGK223 | 0.74086096 |
| 61 | SGK494 | 0.74086096 |
| 62 | MAPK15 | 0.72658139 |
| 63 | PHKG1 | 0.72322527 |
| 64 | PHKG2 | 0.72322527 |
| 65 | HIPK2 | 0.70931984 |
| 66 | CSNK1A1 | 0.68422224 |
| 67 | SYK | 0.68300480 |
| 68 | PRKACA | 0.67451592 |
| 69 | PRKCQ | 0.66730991 |
| 70 | RPS6KA2 | 0.66478586 |
| 71 | PTK2B | 0.63231955 |
| 72 | MAP2K2 | 0.62328411 |
| 73 | STK11 | 0.62014284 |
| 74 | CDK19 | 0.61564323 |
| 75 | AURKA | 0.60914479 |
| 76 | CAMK2A | 0.60282669 |
| 77 | MARK1 | 0.56814118 |
| 78 | PRKCH | 0.56802935 |
| 79 | NEK9 | 0.56681366 |
| 80 | FLT3 | 0.56245235 |
| 81 | OXSR1 | 0.55738464 |
| 82 | CAMKK2 | 0.55508934 |
| 83 | RPS6KA5 | 0.52638150 |
| 84 | LYN | 0.52370376 |
| 85 | PRKCI | 0.51640504 |
| 86 | MUSK | 0.50664249 |
| 87 | IKBKE | 0.50417374 |
| 88 | ITK | 0.47194058 |
| 89 | NTRK3 | 0.46893129 |
| 90 | PRKCA | 0.46671756 |
| 91 | SGK3 | 0.46610013 |
| 92 | CAMK1 | 0.46542208 |
| 93 | MATK | 0.45147275 |
| 94 | CAMK2B | 0.43874155 |
| 95 | PRKAA1 | 0.41956025 |
| 96 | DAPK3 | 0.41282649 |
| 97 | CDK9 | 0.40330166 |
| 98 | PIM2 | 0.39485498 |
| 99 | DAPK1 | 0.39383940 |
| 100 | ERBB2 | 0.38457197 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 2.86459984 |
| 2 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 2.62200427 |
| 3 | Phototransduction_Homo sapiens_hsa04744 | 2.57756466 |
| 4 | Nicotine addiction_Homo sapiens_hsa05033 | 2.51801672 |
| 5 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 2.50100692 |
| 6 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 2.20854070 |
| 7 | Sulfur metabolism_Homo sapiens_hsa00920 | 2.18638814 |
| 8 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 2.17390461 |
| 9 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 2.00443391 |
| 10 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 1.94703718 |
| 11 | Parkinsons disease_Homo sapiens_hsa05012 | 1.94619085 |
| 12 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.82753096 |
| 13 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.81685677 |
| 14 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.78891328 |
| 15 | Morphine addiction_Homo sapiens_hsa05032 | 1.78613534 |
| 16 | Homologous recombination_Homo sapiens_hsa03440 | 1.72310830 |
| 17 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.68917162 |
| 18 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.64653627 |
| 19 | Ribosome_Homo sapiens_hsa03010 | 1.64031464 |
| 20 | Sulfur relay system_Homo sapiens_hsa04122 | 1.60637537 |
| 21 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.53821274 |
| 22 | Alzheimers disease_Homo sapiens_hsa05010 | 1.44839482 |
| 23 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.42696200 |
| 24 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.41357112 |
| 25 | RNA polymerase_Homo sapiens_hsa03020 | 1.36205727 |
| 26 | Olfactory transduction_Homo sapiens_hsa04740 | 1.35891574 |
| 27 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.35439739 |
| 28 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.33058393 |
| 29 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 1.32015440 |
| 30 | Asthma_Homo sapiens_hsa05310 | 1.28351231 |
| 31 | Taste transduction_Homo sapiens_hsa04742 | 1.28271141 |
| 32 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.26687053 |
| 33 | Retinol metabolism_Homo sapiens_hsa00830 | 1.26601231 |
| 34 | Insulin secretion_Homo sapiens_hsa04911 | 1.24283769 |
| 35 | Ether lipid metabolism_Homo sapiens_hsa00565 | 1.23862581 |
| 36 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.23686671 |
| 37 | Protein export_Homo sapiens_hsa03060 | 1.20008347 |
| 38 | Huntingtons disease_Homo sapiens_hsa05016 | 1.18398988 |
| 39 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.17001586 |
| 40 | Circadian entrainment_Homo sapiens_hsa04713 | 1.16964705 |
| 41 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.16824387 |
| 42 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.16034263 |
| 43 | Basal transcription factors_Homo sapiens_hsa03022 | 1.12905309 |
| 44 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.11758674 |
| 45 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 1.10549678 |
| 46 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.07611431 |
| 47 | GABAergic synapse_Homo sapiens_hsa04727 | 1.06287474 |
| 48 | Glutamatergic synapse_Homo sapiens_hsa04724 | 1.01735300 |
| 49 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.01332853 |
| 50 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.98383792 |
| 51 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.96262217 |
| 52 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.95534789 |
| 53 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.94460484 |
| 54 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.94245653 |
| 55 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.91637445 |
| 56 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.90982605 |
| 57 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.85861735 |
| 58 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.83493739 |
| 59 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.83004683 |
| 60 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.80800313 |
| 61 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.78060630 |
| 62 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.76895123 |
| 63 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 0.75433362 |
| 64 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.75109816 |
| 65 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.74992994 |
| 66 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.73823978 |
| 67 | Salivary secretion_Homo sapiens_hsa04970 | 0.71939061 |
| 68 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.71627732 |
| 69 | RNA degradation_Homo sapiens_hsa03018 | 0.70526027 |
| 70 | Melanoma_Homo sapiens_hsa05218 | 0.69506519 |
| 71 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.68736046 |
| 72 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.67972014 |
| 73 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.67144594 |
| 74 | Peroxisome_Homo sapiens_hsa04146 | 0.66581291 |
| 75 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.63433460 |
| 76 | Renin secretion_Homo sapiens_hsa04924 | 0.63189599 |
| 77 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.63030984 |
| 78 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.62941703 |
| 79 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.62663610 |
| 80 | Allograft rejection_Homo sapiens_hsa05330 | 0.59131332 |
| 81 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.58399883 |
| 82 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.56828635 |
| 83 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.55486316 |
| 84 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.55079574 |
| 85 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.54645973 |
| 86 | Cocaine addiction_Homo sapiens_hsa05030 | 0.53494371 |
| 87 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.52989004 |
| 88 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.51674780 |
| 89 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.51316827 |
| 90 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.50890418 |
| 91 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.47426221 |
| 92 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.46173765 |
| 93 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.43854322 |
| 94 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.43474382 |
| 95 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.42438875 |
| 96 | ABC transporters_Homo sapiens_hsa02010 | 0.42382994 |
| 97 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.42013145 |
| 98 | Metabolic pathways_Homo sapiens_hsa01100 | 0.41755552 |
| 99 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.39957810 |
| 100 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.39125091 |

